Improving Treatment Decisions Using Personalized Risk Assessment From the International IgA Nephropathy Prediction Tool
Barbour SJ, Canney M, Coppo R, Zhang H, Liu Z-H, et al., for the International IgA Nephropathy Network
Read MoreBarbour SJ, Canney M, Coppo R, Zhang H, Liu Z-H, et al., for the International IgA Nephropathy Network
Read MoreHazlewood GS, Marshall DA, Barber CEH, Li LC, Barnabe C, Bykerk V, Tugwell P, Hull PM, Bansback N
Read MoreMetcalfe RK, Harrison M, Hutfield A, Lewisch M, Singer J, Magee LA, Bansback N.
Read MoreHarrison M, Bansback N, Aguiar M, Koehn C, Shojania K, Finckh A, Hudson M
Read MoreMulhern B, Bansback N, Norman R, Brazier J, on behalf of the SF-6Dv2 International Project Group
Read MoreTrenaman L, Stacey D, Bryan S, Payne K, Hawker G, Bansback N
Read MorePoureslami I, Shum J, Kopec J, Sawatzky R, Gupta S, Pakhale S, Kassay S, Starnes K, Akhtar A, FitzGerald JM,
Read MoreMunro S, Manski R, Donnelly KZ, Agusti D, Stevens G, et al.
Read MoreBansback N, Chiu JA, Carruthers R, Metcalfe R, Lapointe E, Schabas A, Lenzen M, Lynd LD, Traboulsee A
Read MoreOstermann J, Brown DS, van Til JA, Bansback N, Légaré F, Marshall DA, Bewtra M
Read More